We are live on ! Find out more
FBLG icon

FibroBiologics

17 hedge funds and large institutions have $5.18M invested in FibroBiologics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% more ownership

Funds ownership: 0%0.07% (+0.07%)

Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$2.26M +$2.52M +10,462 New
HF
2
HRT Financial
New York
$619K +$689K +2,867 New
Marshall Wace
3
Marshall Wace
United Kingdom
$562K +$625K +2,601 New
Citigroup
4
Citigroup
New York
$329K +$366K +1,521 New
ECM
5
ExodusPoint Capital Management
New York
$277K +$308K +1,280 New
JP Morgan Chase
6
JP Morgan Chase
New York
$245K +$272K +1,132 New
NA
7
NewEdge Advisors
Louisiana
$194K +$215K +895 New
PD
8
Point72 (DIFC)
United Arab Emirates
$172K +$191K +796 New
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$154K +$171K +712 New
BlackRock
10
BlackRock
New York
$143K +$159K +660 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$119K +$132K +549 New
CSS
12
Cubist Systematic Strategies
Connecticut
$97.1K +$108K +449 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$4K +$4.81K +20 New
AF
14
Allworth Financial
California
$2.82K +$3.13K +13 New
Wells Fargo
15
Wells Fargo
California
$2.16K +$2.4K +10 New
UBS Group
16
UBS Group
Switzerland
$303 +$240 +1 New
Macquarie Group
17
Macquarie Group
Australia
$12 +$13K +54 New

FBLG Hedge Fund Activity: Q1 2024 in Review

17 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q1 2024, worth a combined $5.18M.

Buyers outnumbered sellers: 17 funds opened new FBLG positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $2.52M.

  • 17 institutional investors held FibroBiologics (FBLG) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $5.18M of FibroBiologics stock for Q1 2024.
  • 17 funds opened new FibroBiologics positions in Q1 2024 and 0 closed out, a net change of +17 holders.
  • The largest FibroBiologics buyer in Q1 2024 was Millennium Management, an estimated $2.52M added.

Based on aggregated 13F filings for Q1 2024.